Trial intelligence / Profile preview

Anesthetic Effect on Immune Cells in Breast Cancer Surgery

NCT02758249Completed

Sponsor
Konkuk University Medical Center
Start
Jan 2016
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of propofol injection (veterinary) and sevoflurane in breast cancer (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Immune cell (NK cell and CD8+ T cell) activity up to 24 hours. Started Jan 2016; status: completed.

02

Drugs

propofol injection (veterinary)sevoflurane
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02758249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02758249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call